Profile
Daniel Schwartz is the founder of Serra Pharmaceuticals, Inc. (founded in 1996) and RxSight, Inc. (founded in 1997).
At Serra Pharmaceuticals, he did not hold any titles.
At RxSight, he held the title of Independent Director from 1997 to 2021.
Currently, he is the Director-Retina Division at San Francisco VA Medical Center since 1994 and a Professor at The University of California, San Francisco.
He completed his undergraduate degree at Haverford College and his doctorate at The University of California, San Francisco.
Daniel Schwartz active positions
| Companies | Position | Start |
|---|---|---|
San Francisco VA Medical Center
San Francisco VA Medical Center Medical/Nursing ServicesHealth Services Provides healthcare services | Corporate Officer/Principal | 1993-12-31 |
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Former positions of Daniel Schwartz
| Companies | Position | End |
|---|---|---|
| RXSIGHT, INC. | Founder | 2021-08-09 |
Serra Pharmaceuticals, Inc. | Founder | - |
Training of Daniel Schwartz
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
RxSight, Inc.
RxSight, Inc. Electronic ComponentsElectronic Technology Manufactures and sells photosensitive silicone intraocular lens | Electronic Technology |
Haverford College
Haverford College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
San Francisco VA Medical Center
San Francisco VA Medical Center Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
Serra Pharmaceuticals, Inc. |
- Stock Market
- Insiders
- Daniel Schwartz
















